These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27380512)

  • 21. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
    Schwarze K; Buchanan J; Fermont JM; Dreau H; Tilley MW; Taylor JM; Antoniou P; Knight SJL; Camps C; Pentony MM; Kvikstad EM; Harris S; Popitsch N; Pagnamenta AT; Schuh A; Taylor JC; Wordsworth S
    Genet Med; 2020 Jan; 22(1):85-94. PubMed ID: 31358947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best approaches to drug-resistance surveillance at the country level.
    Cabibbe AM; Cirillo DM
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S40-S41. PubMed ID: 28043601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.
    van de Ven M; IJzerman M; Retèl V; van Harten W; Koffijberg H
    BMC Med Res Methodol; 2022 Mar; 22(1):83. PubMed ID: 35350994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders.
    Runheim H; Pettersson M; Hammarsjö A; Nordgren A; Henriksson M; Lindstrand A; Levin LÅ; Soller MJ
    Sci Rep; 2023 Apr; 13(1):6904. PubMed ID: 37106068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Software updates in the Illumina HiSeq platform affect whole-genome bisulfite sequencing.
    Toh H; Shirane K; Miura F; Kubo N; Ichiyanagi K; Hayashi K; Saitou M; Suyama M; Ito T; Sasaki H
    BMC Genomics; 2017 Jan; 18(1):31. PubMed ID: 28056787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole genome sequencing as the ultimate tool to diagnose tuberculosis.
    van Soolingen D; Jajou R; Mulder A; de Neeling H
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S60-S61. PubMed ID: 28043616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-genome characterization in pedigreed non-human primates using genotyping-by-sequencing (GBS) and imputation.
    Bimber BN; Raboin MJ; Letaw J; Nevonen KA; Spindel JE; McCouch SR; Cervera-Juanes R; Spindel E; Carbone L; Ferguson B; Vinson A
    BMC Genomics; 2016 Aug; 17(1):676. PubMed ID: 27558348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
    Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM
    J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of whole-genome (13X) and capture (87X) resequencing methods for SNP and genotype callings.
    Roux PF; Marthey S; Djari A; Moroldo M; Esquerré D; Estellé J; Klopp C; Lagarrigue S; Demeure O
    Anim Genet; 2015 Feb; 46(1):82-6. PubMed ID: 25515399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
    Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
    BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing.
    Patch AM; Nones K; Kazakoff SH; Newell F; Wood S; Leonard C; Holmes O; Xu Q; Addala V; Creaney J; Robinson BW; Fu S; Geng C; Li T; Zhang W; Liang X; Rao J; Wang J; Tian M; Zhao Y; Teng F; Gou H; Yang B; Jiang H; Mu F; Pearson JV; Waddell N
    PLoS One; 2018; 13(1):e0190264. PubMed ID: 29320538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland.
    Abbott M; McKenzie L; Moran BVG; Heidenreich S; Hernández R; Hocking-Mennie L; Clark C; Gomes J; Lampe A; Baty D; McGowan R; Miedzybrodzka Z; Ryan M
    J Community Genet; 2022 Oct; 13(5):487-501. PubMed ID: 34415556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
    Ezenduka C; Ichoku H; Ochonma O
    J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective.
    Hadker N; Garg S; Costanzo C; Miller JD; Foster T; van der Helm W; Creeden J
    J Med Econ; 2010; 13(4):728-37. PubMed ID: 21138338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the costs of genomic sequencing in cancer control.
    Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
    BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease.
    Mallawaarachchi AC; Hort Y; Cowley MJ; McCabe MJ; Minoche A; Dinger ME; Shine J; Furlong TJ
    Eur J Hum Genet; 2016 Nov; 24(11):1584-1590. PubMed ID: 27165007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Practical Guide to Whole Genome Sequencing in the NICU.
    Seither K; Thompson W; Suhrie K
    Neoreviews; 2024 Mar; 25(3):e139-e150. PubMed ID: 38425198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.